Related Experiment Video
Updated: Oct 18, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
Negotiating Gestational Diabetes Mellitus in India: A National Approach
Uday Thanawala1, Hema Divakar2, Rajesh Jain3
1Thanawala Maternity Home, Navi Mumbai 400701, India.
Medicina (Kaunas, Lithuania)
|September 28, 2021
Summary
India addresses hyperglycemia in pregnancy (HIP) challenges through national and global collaborations. Pragmatic solutions empower healthcare workers to manage and prevent HIP effectively within the country.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- The global rise of diabetes mellitus and hyperglycemia in pregnancy (HIP) necessitates tailored, country-specific management strategies.
- India faces unique challenges in managing HIP due to its specific demographic and healthcare landscape.
Purpose of the Study:
- To review the Indian approach to managing and preventing hyperglycemia in pregnancy.
- To highlight the pragmatic and collaborative strategies employed in India.
Main Methods:
- Review of national and international collaborations in HIP management in India.
- Analysis of practical guidelines developed by Indian health planners.
- Examination of strategies empowering medical and paramedical staff.
Main Results:
- Successful implementation of multipronged strategies to address indigenous HIP challenges.
- Empowerment of healthcare professionals through national and global partnerships.
- Development and dissemination of practical guidelines for ground-level caregivers.
Conclusions:
- India's collaborative and pragmatic approach has been effective in managing and preventing hyperglycemia in pregnancy.
- The Indian experience offers valuable insights for other countries facing similar HIP epidemics.
- Continued focus on practical, accessible solutions is crucial for combating HIP.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
3.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.4K
01:20Pathophysiology of Diabetes
2.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
01:15Diabetes: Management and Pharmacotherapy
570
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
570
01:22Diabetes Mellitus: Overview and Type I Subtype
3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.8K
01:06Oral Hypoglycemic Agents: Glinides
308
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
308
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
346
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
346